Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 10/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 9/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.66 |
| ▸ | HPGD | P15428 | 9/20 | 0.66 |
| ▸ | LMNA | P02545 | 8/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 8/20 | 0.66 |
| ▸ | USP2 | O75604 | 8/20 | 0.66 |
| ▸ | CYP2D6 | P10635 | 8/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 7/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 7/20 | 0.66 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.66 |
| ▸ | CLK4 | Q9HAZ1 | 14/20 | 0.62 |
| ▸ | TSHR | P16473 | 7/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4190842 | 0.94 | CYP1A2 (0.64) | CYP1A2ALDH1A1CYP3A4KDM4EHPGD | |
| SCHEMBL4173317 | 0.92 | CLK4 (0.63) | CYP1A2ALDH1A1CYP3A4KDM4EHPGD | |
| SCHEMBL4188270 | 0.92 | CLK4 (0.65) | CYP1A2ALDH1A1CYP3A4KDM4EHPGD | |
| SCHEMBL4177907 | 0.91 | CLK4 (0.62) | CYP1A2ALDH1A1CYP3A4KDM4EHPGD | |
| SCHEMBL4173682 | 0.91 | CYP1A2 (0.61) | CYP1A2ALDH1A1CYP3A4KDM4EHPGD | |
| SCHEMBL4176590 | 0.91 | LMNA (0.59) | CYP1A2ALDH1A1CYP3A4KDM4EHPGD | |
| SCHEMBL4183776 | 0.90 | CLK4 (0.62) | CYP1A2ALDH1A1CYP3A4KDM4EHPGD | |
| SCHEMBL4181278 | 0.90 | CLK4 (0.66) | CYP1A2ALDH1A1CYP3A4KDM4EHPGD | |
| SCHEMBL4176009 | 0.89 | CLK4 (0.60) | CYP1A2ALDH1A1CYP3A4KDM4EHPGD | |
| SCHEMBL4184752 | 0.89 | CLK4 (0.61) | CYP1A2ALDH1A1CYP3A4KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090069320-A1 | Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof | GRUENENTHAL GMBH (DE) | 2009-03-12 | — | — | US | claimed |
| US-20090069320-A1 | Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof | GRUENENTHAL GMBH (DE) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069320-A1 | Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof | GRM1, GRIN1, GRM2 | CYP1A2 4353/4885ALDH1A1 2269/4885CYP3A4 4173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.